Seeking Alpha

D. Linsenbardt » Comments |

Sort by:
Latest | Highest rated
  • Merck Buries Taranabant: Farewell Cannabinoid Antagonist Field [View article]
    Today Pfizer announced that they pulled out of phase III clinical trials for their CB1 antagonist due to "a changing regulatory environment"...

    I wonder if there is public access various aspects of the pharmacology of these compounds... (i.e. comparisons to Rimonabant)
    Nov 05 17:29 pm |Rating: 0 0 |Link to Comment
Comments by Ticker
D. Linsenbardt's
Comments Stats
1 comment
Rating: 0 (0 - 0 )